PTI reported. PTI sources revealed the Union Health Ministry and the office of Drugs Controller General of India had sought from both the firms their production plan for June, July, August and September.
Hyderabad-based Bharat Biotech's Covaxin and Oxford-AstraZeneca's Covishield, which is manufactured by Pune-based Serum Institute of India, are the two vaccines that are being used for vaccination against COVID-19 in India.
Dr V Krishna Mohan, the Whole-time Director of Bharat Biotech, is learnt to have conveyed to the government that the production of Covaxin would be raised to 3.32 crore in July, and to 7.82 crore in August which will be maintained in September too.Similarly, Prakash Kumar Singh, Director, Government and Regulatory.